|   | | 
ambiguous "natural father." Because one woman may be the genetic  |  | mother of a child while another woman is the gestational mother,  |  | for consistency the term "genetic father" was substituted for  |  | "biological." Definitions are not supplied for such terms as  |  | "unknown father, legal father, real father, and the like," either  |  | because the term is self-defining or because it is ambiguous. |  
  |  
 
 
 |   |  | Subsection (8) was amended in 2002 to clarify that an  |  | individual who becomes a parent through assisted reproduction as  |  | provided in Article 7 is not a "donor." Similarly, if bracketed  |  | Article 8, Gestational Agreement, is enacted, an individual who  |  | is an intended parent through the procedure implemented in that  |  | article is not a "donor." No substantive change is intended by  |  | this clarification. |  
  |  
 
 
 |   |  | Subsection (9), "ethnic or racial group," relates to an  |  | individual only for purposes of genetic testing. The genetic  |  | tests themselves do not determine the race or ethnic group of the  |  | individual. Rather, if a tested individual is not excluded, his  |  | race or ethnic group provided is used in the paternity  |  | calculations because those calculations give the most  |  | conservative result, that is, those most favoring non-paternity. |  
  |  
 
 
 |   |  | Subsection (10), "genetic testing," contemplates that  |  | paternity testing must be broadly defined to include all of the  |  | traditional genetic tests, such as blood types and HLA (Human  |  | Leukocyte Antigen), as well as newer DNA technologies. In the  |  | past the term "blood test" was commonly applied to paternity  |  | testing. However, this usage actually referred to the sample  |  | collected; in fact, the tests were genetic tests performed on  |  | blood samples. The Act uses the scientific term "deoxyribonucleic  |  | acid." This is to accommodate the changes in technology used to  |  | evaluate the DNA. Early DNA testing involved RFLP technology  |  | (Restriction Fragment Length Polymorphism), followed by PCR  |  | techniques (Polymerase Chain Reaction); these may be replaced by  |  | newer technology, such as SNP (Single Nucleotide Polymorphisms).  |  | The type of DNA technology to be employed is best left to  |  | scientific bodies, such as accreditation agencies, see § 503(a),  |  | infra. |  
  |  
 
 
 |   |  | Subsection (11), "gestational mother," is derived from USCACA  |  | (1988) § 1(4), which employed the now-discarded term "surrogate  |  | mother" to define the same factual circumstances dealt with in  |  | bracketed Article 8, Gestational Agreement, infra. For purposes  |  | of this Act, a woman giving birth to her own genetic child,  |  | a.k.a. "birth mother," is distinguished from a "gestational  |  | mother." The former is both a gestational and genetic mother,  |  | while the latter also gives birth to a child, who may or may not  |  | be her genetic child. In the Act the term "gestational mother" is  |  | narrowly defined to restrict it to a  |  
  |  
 
  |